|
๐
|
Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.
78 auth.
R. Clarke,
R. Collins,
S. Lewington,
A. Donald,
G. Alfthan,
J. Tuomilehto,
E. Arnesen,
K. Bรธnaa,
J. Blacher,
G. Boers,
A. Bostom,
M. Bots,
D. Grobbee,
L. Brattstroฬm,
M. Breteler,
...
A. Hofman,
J. Chambers,
J. Kooner,
B. Coull,
R. W. Evans,
L. Kuller,
S. Evers,
A. Folsom,
G. Freyburger,
F. Parrot,
J. Genest,
K. Dalery,
I. Graham,
L. Daly,
E. Hoogeveen,
P. Kostense,
C. Stehouwer,
P. Hopkins,
P. Jacques,
J. Selhub,
F. Luft,
P. Jungers,
A. Lindgren,
Y. Lolin,
F. Loehrer,
B. Fowler,
M. A. Mansoor,
M. Malinow,
P. Ducimetiere,
O. Nygรฅrd,
H. Refsum,
S. Vollset,
P. Ueland,
G. Omenn,
S. Beresford,
J. Roseman,
H. Parving,
M. Gall,
I. Perry,
S. Ebrahim,
A. Shaper,
K. Robinson,
D. Jacobsen,
S. Schwartz,
D. Siscovick,
M. Stampfer,
C. Hennekens,
E. Feskens,
D. Kromhout,
J. Ubbink,
P. Elwood,
J. Pickering,
P. Verhoef,
A. Eckardstein,
H. Schulte,
G. Assmann,
N. Wald,
M. Law,
P. Whincup,
D. Wilcken,
P. Sherliker,
P. Linksted,
G. Smith
|
10 |
2002 |
10
๐
|
|
๐
|
Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial
156 auth.
J. Blackshear,
V. Baker,
F. Rubino,
R. Safford,
G. Lane,
T. Flipse,
J. Malouf,
Randall C. Thompson,
R. Webel,
G. Flaker,
L. Young,
D. Hess,
G. Friedman,
R. Burger,
J. Mcanulty,
...
B. Coull,
C. Marchant,
J. Timberg,
C. Janzik,
G. Giraud,
B. Halperin,
J. Kron,
M. Wynn,
M. Raitt,
David C. Anderson,
R. Asinger,
S. Newburg,
J. Fifield,
S. Bundlie,
R. Koller,
R. Tarrel,
C. Dick,
J. Haugland,
C. Jorgensen,
A. Leonard,
M. C. Kanter,
D. Solomon,
M. Zabalgoitia,
D. Mego,
J. Carter,
S. Y. Boyd,
B. Boop,
D. Lalonde,
R. Modlin,
W. Logan,
B. Green,
W. P. Hamilton,
L. Mezei,
S. Riggio,
G. Feldman,
A. D. Hayward,
R. Strauss,
W. Anderson,
J. Grover,
M. Mckenzie,
P. Hart-McArthur,
M. Gramberg,
H. Houston,
J. Halperin,
E. B. Rothauf,
J. Weinberger,
M. Goldman,
A. Laupacis,
K. Chan,
P. Bourque,
J. Biggs,
A. Ives,
W. Feinberg,
K. Kern,
G. Pennock,
P. Fenster,
B. J. Huerta,
J. Ohm,
H. Dittrich,
C. Kerridge,
W. Keen,
M. Swenson,
S. Kopecky,
S. Litin,
D. Wiebers,
Anne E Holland,
RonaldD. Brown,
B. Khandheria,
I. Meissner,
K. Tucker,
R. Rothbart,
J. Torelli,
J. Schmidt,
D. Murray,
R. S. Ruzich,
H. Loutfi,
C. Appleton,
T. Ingall,
L. Carlson,
D. Wilson,
M. Dunn,
B. Nolte,
C. Edwards,
A. Dick,
L. A. Price,
D. Janosik,
P. Bjerregaard,
A. Quattromani,
L. Schiller,
A. Labovitz,
C. Burch,
B. J. Parks,
D. Thompson,
L. Berarducci,
S. Carey,
A. Vigil,
R. Falk,
N. Battinelli,
M. McNeil,
R. Davidoff,
S. Bernard,
P. Bergethon,
L. Fiori,
G. Albers,
E. Atwood,
J. M. Clark,
D. Tong,
M. Yenari,
V. Froelicker,
H. Lutsep,
N. Hock,
S. Quaglietti,
S. Kemp,
M. Alpert,
J. Rothrock,
C. Hupp,
C. Massey,
W. Hamilton,
V. Miller,
J. Fox,
R. Kronmal,
R. Mcbride,
E. Nasco,
L. Pearce,
K. Fletcher,
J. Koehler,
R. Hart,
D. Sherman,
R. Talbert,
P. A. Heberling,
C. Kajzer,
E. Bovill,
D. Geffken,
E. Cornell,
S. Nightingale,
S. Kelsy,
D. Levy,
J. Marsh,
K. Welch,
J. Marler,
M. D. Walker
|
10 |
1996 |
10
๐
|
|
๐
|
Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease.
9 auth.
M. Malinow,
S. S. Kang,
L. Taylor,
P. Wong,
B. Coull,
T. Inahara,
...
D. Mukerjee,
G. Sexton,
B. Upson
|
9 |
1989 |
9
๐
|
|
๐
|
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
27 auth.
W. Kernan,
C. Viscoli,
K. Furie,
L. Young,
S. Inzucchi,
M. Gorman,
P. Guarino,
A. Lovejoy,
P. Peduzzi,
R. Conwit,
L. Brass,
G. Schwartz,
H. Adams,
L. Berger,
A. Carolei,
...
W. Clark,
B. Coull,
G. Ford,
D. Kleindorfer,
J. OโLeary,
M. Parsons,
P. Ringleb,
S. Sen,
J. Spence,
D. Tannรฉ,
David Wang,
T. Winder
|
9 |
2016 |
9
๐
|
|
๐ฆ
|
Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
B. Coull,
M. Malinow,
N. Beamer,
Gary Sexton,
Frank Nordt,
Pat De Garmo
|
8 |
1990 |
8
๐ฆ
|
|
๐
|
Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Cerebral Embolism Study Group.
15 auth.
R. Hart,
Kathleen I. Lock-Wood,
A. Hakim,
R. Koller,
J. Davenport,
B. Coull,
R. Brey,
A. Furlan,
B. O'neill,
L. Pettigrew,
...
A. Nath,
F. Yatsu,
D. Sherman,
J. Easton,
V. Miller
|
8 |
1984 |
8
๐
|
|
๐ฌ
|
Neurological disease associated with antiphospholipid antibodies
D. Briley,
B. Coull,
S. Goodnight
|
8 |
1989 |
8
๐ฌ
|
|
๐
|
Treatment of Hyperglycemia In Ischemic Stroke (THIS): A Randomized Pilot Trial
8 auth.
Askiel Bruno,
T. Kent,
B. Coull,
R. Shankar,
C. Saha,
K. Becker,
...
B. Kissela,
L. Williams
|
7 |
2008 |
7
๐
|
|
๐ฌ
|
Interleukinโ6 and interleukinโ1 receptor antagonist in acute stroke
N. Beamer,
B. Coull,
W. Clark,
J. Hazel,
Jenny R. Silberger
|
7 |
1995 |
7
๐ฌ
|
|
๐ฌ
|
Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study.
R. Hart,
B. Coull,
D. Hart
|
7 |
1983 |
7
๐ฌ
|
|
๐
|
Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial.
9 auth.
J. C. Grotta,
Wayne M. Clark,
B. Coull,
L. Pettigrew,
Bruce Mackay,
L. B. Goldstein,
...
Irene Meissner,
Deborah Murphy,
Linda LaRue
|
7 |
1995 |
7
๐
|
|
๐ข
|
Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke.
S. Barnwell,
W. Clark,
Tung T. Nguyen,
O. R. O'Neill,
M. Wynn,
B. Coull
|
7 |
1994 |
7
๐ข
|
